1. Home
  2. VRTS vs SPRY Comparison

VRTS vs SPRY Comparison

Compare VRTS & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRTS
  • SPRY
  • Stock Information
  • Founded
  • VRTS 1988
  • SPRY 2015
  • Country
  • VRTS United States
  • SPRY United States
  • Employees
  • VRTS N/A
  • SPRY N/A
  • Industry
  • VRTS Investment Managers
  • SPRY Biotechnology: Pharmaceutical Preparations
  • Sector
  • VRTS Finance
  • SPRY Health Care
  • Exchange
  • VRTS Nasdaq
  • SPRY Nasdaq
  • Market Cap
  • VRTS 1.3B
  • SPRY 1.1B
  • IPO Year
  • VRTS 1992
  • SPRY N/A
  • Fundamental
  • Price
  • VRTS $184.07
  • SPRY $9.92
  • Analyst Decision
  • VRTS Hold
  • SPRY Strong Buy
  • Analyst Count
  • VRTS 4
  • SPRY 4
  • Target Price
  • VRTS $190.50
  • SPRY $31.25
  • AVG Volume (30 Days)
  • VRTS 91.6K
  • SPRY 2.4M
  • Earning Date
  • VRTS 10-24-2025
  • SPRY 11-12-2025
  • Dividend Yield
  • VRTS 5.22%
  • SPRY N/A
  • EPS Growth
  • VRTS 37.35
  • SPRY N/A
  • EPS
  • VRTS 20.53
  • SPRY N/A
  • Revenue
  • VRTS $888,980,000.00
  • SPRY $112,339,000.00
  • Revenue This Year
  • VRTS N/A
  • SPRY N/A
  • Revenue Next Year
  • VRTS $1.36
  • SPRY $186.14
  • P/E Ratio
  • VRTS $8.96
  • SPRY N/A
  • Revenue Growth
  • VRTS 0.99
  • SPRY 22367.80
  • 52 Week Low
  • VRTS $142.18
  • SPRY $9.34
  • 52 Week High
  • VRTS $252.82
  • SPRY $18.90
  • Technical
  • Relative Strength Index (RSI)
  • VRTS 41.12
  • SPRY 39.81
  • Support Level
  • VRTS $180.80
  • SPRY $9.75
  • Resistance Level
  • VRTS $195.00
  • SPRY $11.15
  • Average True Range (ATR)
  • VRTS 5.06
  • SPRY 0.64
  • MACD
  • VRTS -0.60
  • SPRY 0.06
  • Stochastic Oscillator
  • VRTS 22.99
  • SPRY 9.46

About VRTS Virtus Investment Partners Inc.

Virtus Investment Partners Inc provides investment management and related services to institutions and individuals. It uses a multi-manager, multi-style approach, offering investment strategies from investment managers, each having its distinct investment style, autonomous investment process, and individual brand, as well as from select unaffiliated managers for certain funds. Through its multi-manager model, the group provides investment managers with distribution, business, and operational support. The Company operates in one business segment, namely as an asset manager providing investment management and related services for individual and institutional clients.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Share on Social Networks: